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Abstract 
 
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) biopsy sampling of 
enlarged lymph nodes is increasingly used to diagnose metastatic tumors, especially of the 
gastrointestinal tract and the lungs. Herein, we describe the diagnosis of metastatic renal 
cell carcinoma from a native kidney of a 54 year-old male patient, who had a 5-years 
history of renal transplant, by EUS-FNA of mediastinal and celiac lymph nodes. Histological 
and immunohistochemical findings confirmed the origin of metastatic tumor. EUS-FNA with 
proper cytological evaluation can be useful in the diagnosis of metastatic renal cell 
carcinoma in renal transplant patients. Copyright: The Authors. 
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Introduction 
 
Endoscopic ultrasound-guided fine needle 
aspiration (EUS-FNA) biopsy is increasingly 
used to diagnose metastatic tumors. 
Lymph node sampling by fine needle 
aspiration (FNA) offers a chance to evaluate 
the origin of tumor cells, and subsequently 
aid the management of such tumors. 
Herein, we present a case of metastatic 
renal cell carcinoma (RCC) of the native 
kidney, in a renal transplant patient, 
diagnosed by EUS-FNA biopsy of the 
mediastinal and celiac lymph nodes. 
 
Case report 
 
Informed Consent was obtained from the 
patient as per the policy of our institution. 
A 54 year old male patient with a 5-year 
history of living-related donor renal 
transplant, secondary to Goodpasture 
syndrome, presented with nausea, vomiting 
and moderate lower abdominal pain for 3 
weeks. The patient also reported a 10 lb 
weight loss in 2 months. He had a history 
of smoking, 25 packs of cigarettes per year, 
but quit about 6 years earlier. His father 
died of renal cancer at the age of 60. At 
presentation, he was afebrile and 
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Figure 1. A, Renal ultrasound revealed multiple hypoechoic lesions in the right native kidney. 
Abdominal MRI showed an enlarged right native kidney with irregular margins (B).  Additionally, 
retroperitoneal adenopathy was observed (C). 
 
 
normotensive. Abdominal examination 
revealed a soft non-tender abdomen, with 
no graft tenderness. Laboratory work-up 
showed white blood cell counts of 7.4 
×109/L, hemoglobin of 9.5 g/dL, and 
platelets of 311 x 109/L. His serum 
creatinine was 3.27 mg/dL (his baseline 
creatinine was 2mg/dL) while electrolytes 
were within normal limits. Liver function 
test, amylase and lipase were all within 
normal limits. Renal ultrasound revealed 
multiple hypoechoic lesions in the right 
native kidney, which were possibly solid in 
nature (Figure 1 A). The patient underwent 
abdominal magnetic resonance imaging 
(MRI) for further evaluation of these 
lesions. MRI revealed an enlarged right 
native kidney with irregular margins. 
Additionally, retroperitoneal adenopathy 
was observed below the level of the left 
renal vein, with largest lymph node 
measures of approximately 4.7 x 3.8 cm in 
cross-section below the left kidney (Figure 
1 B, C). Positron emission tomography 
(PET) scan revealed significant 
supraclavicular, mediastinal and 
retrocrural adenopathy in addition to the 
extensive retroperitoneal adenopathy. The 
right native kidney showed abnormal 
enlargement and increased 
radiopharmaceutical accumulation which 
is abnormal in the setting of renal 
transplant history with atrophic native 
kidneys. Abnormal uptake was also 
identified in the T11 vertebral body, L3 
vertebral body and in the posterior column 
of the right acetabulum which could 
represent bone metastases (Figure 2). The 
patient was scheduled for EUS to evaluate 
the perigastric/peripancreatic area for 
possible FNA of lymph nodes. EUS revealed 
multiple large round and hypoechoic 
mediastinal lymphadenopathy distributed 
between the subcarinal and the 
paraesophageal areas, and at the 
peripancreatic/periduodenal areas, the 
largest measured 33.7 mm x 21.2 mm in 
size (Figure 3 A). Additionally multiple 
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Figure 2. PET scan: Abnormal uptake in T11, 
L3 and the right acetabulum; significant 
supraclavicular, mediastinal and retrocrural 
adenopathy in addition to the extensive 
retroperitoneal adenopathy; abnormal 
enlargement of right kidney. 
 
 
celiac lymph nodes were identified, the 
largest measured 20.9 mm x 14.5 mm. 
EUS-FNA of enlarged celiac lymph node 
was performed (Figure 3 B). The histologic 
features showed enlarged and 
hyperchromatic tumor cells without 
polarity (Figures 3 C, D). Histochemical 
findings were consistent with metastatic 
adenocarcinoma of kidney origin (Positive = 
PAX8 and vimentin; Negative = CK7, CK20, 
CDX-2, S100, TTF-1, Pan CK, data not 
shown). The patient was started on 
chemotherapy and referred for palliative 
radiotherapy but he decided to discontinue 
treatment and proceeded with Hospice 
Care. 
 
Discussion 
 
RCC is an increasingly incident malignant 
tumor that accounts for 2–3% of all adult 
malignancies (1; 2). Smoking is one of the 
most recognized risk factors for RCC (3). 
Once patients developed metastatic 
disease, their prognosis is poor with a 
median survival of about 13 months (4). 
About 30% of patients with RCC have 
metastatic disease at the time of 
presentation with lungs, lymph nodes, 
liver, and bone being the common sites (2). 
Similar to other malignancies, diagnosis 
mainly relies on tissue sampling of the 
primary tumor or secondary metastasis. 
Sometimes, metastatic lesions could be the 
first presentation of the tumor, and 
sampling of these secondary lesions could 
point to the primary origin. With the 
increasing use of EUS in evaluation and 
sampling of lymph nodes and 
gastrointestinal masses, it could also assist 
in the diagnosis of metastatic RCC. The 
role of EUS in the diagnosis of metastatic 
RCC has been discussed in the literature. 
In most cases, EUS was used to evaluate 
pancreatic masses, which then were 
diagnosed as secondary metastasis from 
RCC. Be´chade et al. used EUS-FNA in 11 
patients, who had a history of RCC and a 
solid mass within the pancreas, and 
identified 9 of them having pancreatic 
metastases of RCC (5). Additionally, Waters 
et al. did a retrospective review of 66 
patients who underwent EUS-FNA for 
tumors that have metastasized to the 
pancreas and found that the most common 
site of origin for these metastases was 
kidney (27 [41%] cases) (6).  
 
Another possible role of EUS in diagnosis of 
metastatic RCC is sampling of the 
metastatic lymph nodes. The mediastinum 
is one of the common sites of metastases 
from RCC. This makes EUS a proper 
diagnostic modality in this setting. 
Fritscher-Ravens et al. used EUS-FNA in 
111 patients for evaluation of mediastinal 
lymph nodes. Seven patients were 
diagnosed by cytology to have metastatic 
RCC, and four of them were first diagnosed 
based on this study (7). This makes EUS-
FNA a less invasive technique for 
evaluation of mediastinal lymph nodes, 
which then can lead to the diagnosis of 
metastatic RCC. Additionally, 
endobronchial ultrasound has been used 
similarly to diagnose metastatic RCC to the 
mediastinum (8; 9). 
 
In our case, we used EUS-FNA biopsy to 
diagnose metastatic RCC. Our patient had 
radiological finding of multiple enlarged 
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Figure 3. A, EUS showed an enlarged peripancreatic/periduodenal lymph node; B, EUS-FNA of 
enlarged celiac lymph node; Enlarged and hyperchromatic tumor cells (Diff Quickistain) displaying 
lack of polarity in low power (C), and high power (D). 
 
 
lymph nodes in the mediastinum and 
abdomen. By using EUS, we were able to 
access both the mediastinal and celiac 
lymph nodes and obtain multiple FNAs 
from both lymph nodes, and we were able 
to accurately diagnose the site of origin of 
the metastases. Our case is unique in 
multiple aspects. First, our patient had a 
history of renal transplantation, and he 
developed metastatic RCC of the native 
kidney. To the best of our knowledge, there 
are no similar case reports of EUS-FNA of 
lymph nodes used in the diagnosis of 
metastatic RCC in renal transplant 
patients. Studies suggest that kidney 
cancer is approximately 15-fold more 
common in renal transplant patients 
compared to general population, in 
addition to the increased risk of other 
malignancies, which could be related to 
immunosuppressive medications or viral 
infections (10). This risk, in addition to 
smoking and family history, may have 
contributed to the development of RCC in 
our patient. Second, the extensive lymph 
node involvement in our patient was more 
suggestive of lymphoma rather than RCC. 
EUS-FNA biopsy helped in confirming the 
diagnosis as metastatic adenocarcinoma of 
kidney origin.  
 
Conclusion  
 
EUS-FNA biopsy can be useful in the 
diagnosis of metastatic RCC in renal 
transplant patients. It can contribute to 
diagnosis by sampling mediastinal lymph 
nodes or pancreatic masses. Proper 
cytological evaluation can identify the 
primary source and guide therapy. 
 
Conflict of interest 
 
The authors declare that they have no 
competing interests. 
 
References 
 
1. Rini BI, Campbell SC, Escudier B. Renal 
cell carcinoma. Lancet. 
2009;373(9669):1119-32 
Doi: 
http://dx.doi.org/10.1016/S0140-
6736(09)60229-4 
 
Alastal et al.                                                                                                      EUS-FNA biopsy for renal cell carcinoma 
 
Journal of Kidney Cancer and VHL 2015; 2(2):70-74.               http://jkcvhl.com  74 
 
2. Abe H, Kamai T. Recent advances in the 
treatment of metastatic renal cell 
carcinoma. Int J Urol. 2013;20(10):944-55. 
Doi: 
http://dx.doi.org/10.1111/iju.12187 
 
3. Theis RP, Dolwick Grieb SM, Burr D, 
Siddiqui T, Asal NR. Smoking, 
environmental tobacco smoke, and risk of 
renal cell cancer: a population-based case-
control study. BMC Cancer. 2008;8:387. 
Doi: 
http://dx.doi.org/10.1186/1471-2407-8-
387 
 
4. Cohen HT, McGovern FJ. Renal-cell 
carcinoma. N Engl J Med. 
2005;353(23):2477-90. 
Doi: 
http://dx.doi.org/10.1056/NEJMra043172 
 
5. Béchade D, Palazzo L, Fabre M, Algayres 
JP. EUS-guided FNA of pancreatic 
metastasis from renal cell carcinoma. 
Gastrointest Endosc. 2003;58(5):784-8. 
Doi: 
http://dx.doi.org/10.1016/S0016-
5107(03)02034-0 
 
6. Waters L, Si Q, Caraway N, Mody D, 
Staerkel G, Sneige N. Secondary tumors of 
the pancreas diagnosed by endoscopic 
ultrasound-guided fine-needle aspiration: a 
10-year experience. Diagn Cytopathol. 
2014;42(9):738-43. 
Doi: 
http://dx.doi.org/10.1002/dc.23114 
7. Fritscher-Ravens A, Sriram PV, Topalidis 
T, Jaeckle S, Thonke F, Soehendra N. 
Endoscopic ultrasonography-guided fine-
needle cytodiagnosis of mediastinal 
metastases from renal cell cancer. 
Endoscopy. 2000;32(7):531-5. 
Doi: 
http://dx.doi.org/10.1055/s-2000-3815 
 
8. Nakajima T, Yasufuku K, Wong M, Iyoda 
A, Suzuki M, Sekine Y, Shibuya K, 
Hiroshima K, Iizasa T, Fujisawa T. 
Histological diagnosis of mediastinal lymph 
node metastases from renal cell carcinoma 
by endobronchial ultrasound-guided 
transbronchial needle aspiration. 
Respirology. 2007;12(2):302-3. 
Doi: 
http://dx.doi.org/10.1111/j.1440-
1843.2006.01023.x 
 
9. Lew M, Foo WC, Roh MH. Diagnosis of 
metastatic renal cell carcinoma on fine-
needle aspiration cytology. Arch Pathol Lab 
Med. 2014;138(10):1278-85. 
Doi: 
http://dx.doi.org/10.5858/arpa.2014-
0283-CC 
 
10. Kasiske BL, Snyder JJ, Gilbertson DT, 
Wang C. Cancer after kidney 
transplantation in the United States. Am J 
Transplant. 2004;4(6):905-13. 
Doi: 
http://dx.doi.org/10.1111/j.1600-
6143.2004.00450.x 
 
 
 
